Skip to main content
Equibles

Bank of New York Mellon Corp

Bank

Position in AURA — Aura Biosciences, Inc.

CIK 1390777 NEW YORK, NY
Back to AURA Full portfolio

Position in AURA

as of Jun 30, 2026 · filed Aug 6, 2026
Position Value
$842,010
+$176,805 QoQ
Shares Held
118,593
+19.3% QoQ
Ownership
0.114%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#49
of 146 holders
Holding Since
Mar 2022
18 quarters on record
Voting authority Sole 98% Shared 0% None 2%

Common Shares in AURA Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Bank of New York Mellon Corp holds $4,864,365,655 across 311 Biotechnology names. AURA ranks #207 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 1,672,623 $830,842,010
2 REGN
Regeneron Pharmaceuticals, Inc.
 758,492 $472,950,091
3 JAZZ
Jazz Pharmaceuticals plc
 1,578,013 $380,253,782
4 ALNY
Alnylam Pharmaceuticals, Inc.
 492,071 $148,128,128
5 INSM
INSMED Inc
 1,312,756 $139,966,036
6 MRNA
Moderna, Inc.
 1,701,675 $119,168,293
7 RVMD
Revolution Medicines, Inc.
 601,056 $112,565,759
8 INCY
Incyte Corp
 972,825 $110,279,435

All Filings in AURA

Export CSV
18 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $842,010 118,593
2026-03-31 $665,205 99,433
2025-12-31 $588,179 107,923
2025-09-30 $591,647 95,736
2025-06-30 $583,938 93,281
2025-03-31 $627,317 107,051
2024-12-31 $873,538 106,270
2024-09-30 $943,799 105,926
2024-06-30 $1,081,282 143,027
2024-03-31 $741,651 94,478
2023-12-31 $799,924 90,285
2023-09-30 $752,071 83,843
2023-06-30 $1,021,628 82,723
2023-03-31 $600,035 64,659
2022-12-31 $526,007 50,096
2022-09-30 $912,088 50,336
2022-06-30 $568,160 40,096
2022-03-31 $318,912 14,496